The SNS Insider report indicates that in 2022, the pharmacovigilance market had a valuation of USD 6.6 billion, and it is projected to attain USD 11.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8% during the forecast period spanning from 2023 to 2030.
Pharmacovigilance, often abbreviated as PV, is a crucial component of the healthcare and pharmaceutical industries aimed at ensuring the safety and effectiveness of medications and medical products. It involves the systematic monitoring, assessment, and management of the adverse effects or any other drug-related problems associated with pharmaceutical products post-marketing approval. The primary goal of pharmacovigilance is to protect patient health and well-being by identifying and minimizing risks associated with the use of medicines while maximizing their benefits.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/3095
Market Analysis
The pharmacovigilance market has been growing steadily over the years, and several key drivers are contributing to its continued expansion. The rising global population, along with aging demographics in many countries, has led to an increased demand for pharmaceuticals. This growth in drug consumption inherently translates into a greater need for pharmacovigilance services to monitor and manage adverse drug reactions. Rapid advancements in medical research, including the development of biologics, personalized medicine, and gene therapies, introduce new and complex drugs into the market. These innovations bring along unique safety challenges, necessitating robust pharmacovigilance efforts. The adoption of advanced technologies such as artificial intelligence (AI), machine learning, and big data analytics has revolutionized pharmacovigilance. These technologies enable faster and more accurate identification of adverse events, contributing to the growth of the market. The shift towards patient-centric healthcare emphasizes patient safety and involvement in decision-making. Patients are encouraged to report adverse drug reactions directly, increasing the volume of data that pharmacovigilance professionals must manage.
Major Players Listed in the Report are as Follows:
Accenture, IQVIA, Cognizant, IBM Corp, Wipro Ltd, BioClinica Inc, Capgemini, ArisGlobal, ITClinical. ClinChoice.
Pharmacovigilance Market Segmentation as Follows:
By product Life Cycle
- Pre-Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
By Service Provider Outlook
- In-house
- Contract Outsourcing
By Type Outlook
- Spontaneous reporting
- Intensified ADR Reporting
- EHE mining
Process Flow Outlook
- Case Data management
- Signal Detection
- Risk Management System
Therapeutic Outlook
- Oncology
- Neurology
- Cardiology
- Respiratory systems
- Others
End Use Outlook
- Pharmaceuticals
- Medical Device manufacturers
- Others
Impact of Recession
The impact of an ongoing recession on the pharmacovigilance market is multifaceted and can vary depending on regional economic conditions and the strategies adopted by pharmaceutical companies and pharmacovigilance service providers. While budget constraints may pose challenges, increased regulatory scrutiny and outsourcing opportunities could stimulate growth in certain segments of the market. Adapting to the changing economic landscape through diversification and innovation may be key for long-term success in this industry during times of economic uncertainty.
Segmentation Analysis
The pharmaceuticals segment is set to be a dominant force in the ever-evolving field of pharmacovigilance. This segment’s ascension can be attributed to several key factors, including the increasing complexity of drug development, rising patient expectations for drug safety, and stricter regulatory requirements. The case data management segment is positioned as a pivotal player in the pharmacovigilance market, underpinning the effective monitoring and management of drug safety. Its significance is rooted in its ability to collect, process, and analyze vast volumes of adverse event data, thereby safeguarding patients and upholding the pharmaceutical industry’s integrity.
Need Customized Report as per Your Business Requirement Ask Here: https://www.snsinsider.com/enquiry/3095
Regional Status & Analysis
North America is a dominant region in the global pharmacovigilance market, owing to its well-established pharmaceutical industry and stringent regulatory framework led by the FDA. The European Medicines Agency (EMA) plays a pivotal role in regulating drug safety in the European Union (EU). The market in Europe is influenced by EMA regulations and guidelines. The Asia-Pacific region is witnessing significant growth in pharmacovigilance due to the expansion of pharmaceutical markets, especially in countries like India and China. Regulatory agencies in the region are strengthening their pharmacovigilance frameworks, making it essential for pharmaceutical companies to comply with stringent safety reporting requirements.
Conclusion
The future prospects for the market are highly promising, driven by several key factors that continue to shape the pharmaceutical and healthcare industries. As the pharmaceutical industry becomes increasingly global, collaboration between regulatory agencies, pharmaceutical companies, and healthcare providers will become essential. This collaboration will lead to harmonization of pharmacovigilance standards and practices across regions, streamlining the drug safety process. The emergence of advanced therapies such as gene therapy and cell therapy will necessitate specialized pharmacovigilance approaches. Monitoring the long-term safety of these innovative treatments will be a priority.
Frequently Asked Questions
What is the projected outlook for pharmacovigilance market growth?
The global market is projected to attain USD 11.17 billion by 2030, exhibiting a CAGR of 6.8% during the forecast period spanning from 2023 to 2030.
What are the major factors influencing the pharmacovigilance market?
The market is poised for continued growth due to the confluence of factors such as increased drug consumption, regulatory demands, technological advancements, and the globalization of the pharmaceutical industry.
Who are the leading players in the pharmacovigilance market?
Accenture, IQVIA, Wipro Ltd, BioClinica Inc, Cognizant, IBM Corp, Capgemini, ArisGlobal.
Buy Complete Research Report: https://www.snsinsider.com/checkout/3095
Table of Content
Chapter 1 Introduction
Chapter 2 Research Methodology
Chapter 3 Pharmacovigilance Market Dynamics
Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)
Chapter 5 Value Chain Analysis
Chapter 6 Porter’s 5 forces model
Chapter 7 PEST Analysis
Chapter 8 Pharmacovigilance Market Segmentation, By Product Life Cycle
Chapter 9 Pharmacovigilance Market Segmentation, By Service Provider Outlook
Chapter 10 Pharmacovigilance Market Segmentation, By Type Outlook
Chapter 11 Pharmacovigilance Market Segmentation, By Process Flow Outlook
Chapter 12 Pharmacovigilance Market Segmentation, By Therapeutic Outlook
Chapter 13 Pharmacovigilance Market Segmentation, By End Use Outlook
Chapter 14 Regional Analysis
Chapter 15 Company profile
Chapter 16 Competitive Landscape
Chapter 17 Use Case and Best Practices
Chapter 18 Conclusion
Other Report
Cone Beam Computed Tomography Market
Contrast Media/Contrast Agent Market
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Information:
Contact Us: Akash Anand – Head of Business Development & Strategy, [email protected], Phone: +1-415-230-0044 (US) | +91-7798602273 (IND), Website: https://www.snsinsider.com/
Tags:
Go Media, Extended Distribution, BNN, iCN Internal Distribution, Research Newswire, English